-
Trump earned over $1 bn from crypto ventures in 2025
-
Indian sailors fear returning to Gulf after Middle East war
-
The Afghan women farmers keeping their village alive
-
Fear and anger brew inside Meta amid AI frenzy
-
Asian stocks fluctuate as traders eye crucial US jobs data
-
After 250 years, the 'American dream' is tarnished but alive
-
Madison Square Garden: from Nazis to Knicks, and now... Taylor's wedding?
-
'I'm going to stay calm': 48 hours under the rubble in Venezuela
-
'Love it': Wimbledon's military stewards tradition turns 80
-
Breakaway Catholic sect defies Vatican again by ordaining bishops
-
Venezuela quake survivors cherish kindness of strangers
-
Mexico v Ecuador World Cup game delayed by one hour: FIFA
-
US deports first migrant to Pacific nation Palau
-
Talks in Qatar after US-Iran deal: What we know
-
Potter admits Sweden couldn't live with France in World Cup defeat
-
Tuchel refuses to dampen England World Cup expectations
-
US coach dismisses European jinx ahead of Bosnia clash
-
Mbappe hails unity as France rally around Deschamps at World Cup
-
World Bank to phase out lending to China by 2031
-
Mbappe fires France into World Cup last 16, Norway advance
-
Mbappe scores twice as France breeze past Sweden into World Cup last 16
-
Belgium fully fit ahead of Senegal tie at World Cup, says Garcia
-
No corn dogs? Trump's 'Great American State Fair' threatens to be a flop
-
Tepid outlook weighs on Nike despite tariff refund boost
-
Haaland hailed as 'greatest' after more World Cup heroics
-
DR Congo have 'nothing to lose' in England World Cup clash
-
Koeman steps down as Netherlands coach after World Cup exit
-
Valiant Serena beaten on Wimbledon return, Swiatek survives scare
-
Nasdaq ends best quarter in 6 years as yen extends drop against dollar
-
Serena beaten at Wimbledon in first singles match in four years
-
Zverev says Wimbledon hopes 'about me' despite open draw
-
Dutch football chiefs condemn online racism after World Cup exit
-
Lionel Scaloni: Argentina's mastermind marks 100 games in charge
-
Police hunt for Monaco bomber after Ukraine-born tycoon wounded
-
Mourinho's Real Madrid host Real Sociedad in La Liga opener
-
CIA boss compares cutting-edge AI to nuclear weapons
-
Football brings joy to Venezuelan kids displaced by quakes
-
'Any team can beat you', warns Ruiz as Spain seek end to World Cup woe
-
Haaland fires Norway into last 16 as France, Mexico look to advance
-
Venezuela quake survivors seek food, shelter as toll rises to nearly 2,000
-
Merkel unveils official portrait for German chancellery
-
Haaland scores winner to send Norway into last-16 Brazil clash
-
Canada crews battle northern wildfire after crash kills 3
-
US Treasury sanctions target alleged drug cartel-linked fuel smuggling ring
-
Portugal's Silva bides his time after being benched at World Cup
-
LeBron James to leave Lakers to play 24th NBA season
-
US stars relish soccer's primetime moment against Bosnia
-
Zverev wins in four sets to reach Wimbledon round two
-
Lampard extends Coventry stay after promotion to Premier League
-
Grimaldo realises goal of Atletico Madrid move from Leverkusen
Sannabis, Inc. (OTC:USPS) Announces Supplier Agreement with Licensed Colombian Grower to Stock Sannabis Human Fine Clinics and Pharmacy
Sannabis S.A.S. doctors will lead nationwide medical cannabis education as Colombia enters a new regulatory phase for cannabis flower distribution.
CALI, CO / ACCESS Newswire / November 24, 2025 / Sannabis, Inc., f/k/a Ultimate Sports, Inc. (OTC:USPS), a U.S. Company (the "Company") planning to acquire Sannabis S.A.S ("Sannabis") in Colombia, is pleased to announce that Sannabis has entered into a supply agreement with a licensed Colombian cannabis cultivator to provide Sannabis-branded cannabis flower for distribution through the Sannabis Human Fine IPS Health Clinics and the Sannabis Human Fine Pharmacy-expected to be among the first authorized dispensaries in Colombia.
Under this new agreement, Sannabis will receive a consistent supply of high-quality, compliant cannabis flower cultivated specifically for medical use. The product will be used in the Human Fine's clinics, in partnership with Sannabis, for patient prescriptions and distributed through its pharmacy in accordance with upcoming national regulations.
Medical Leadership: Sannabis Doctors to Train Physicians Nationwide
To support the safe, effective, and compliant rollout of medical cannabis flower nationwide, Sannabis' medical team will begin hosting professional workshops for physicians, providing training on:
How to prescribe cannabis flower responsibly
Matching cannabinoid profiles to individual patient needs
Safe integration of cannabis oil and flower into treatment plans
Standard-of-care protocols for chronic pain, anxiety, sleep disorders, and other conditions
These workshops position Sannabis as a leader in Colombia's evolving medical cannabis ecosystem.
Advancing National Policy-Continuing a Legacy From 2015
Sannabis has formally submitted regulatory proposals to the Ministry of Justice outlining a structured, transparent framework for commercial cannabis distribution. This continues the Company's longstanding role in shaping Colombian cannabis regulations.
In 2015, Sannabis hosted national and regional government officials at its operations on an Indigenous Reservation, contributing directly to the protocols used in Colombia's first cannabis legalization decree.
"Now that Colombia is regulating cannabis flower for medical distribution, Sannabis is once again stepping up with constructive, experience-based recommendations that prioritize patient access, product safety, and transparent oversight," said Juan P. Guzman, CEO of Sannabis, Inc. and Director of Sannabis S.A.S.
Upcoming Distribution Announcements
Sannabis will announce its commercial distribution plan once the Ministry finalizes regulations and approves the Sannabis proposed protocols. Initial plans include expanding pharmacy operations, scaling supply capacity, and establishing distribution routes through health-sector partners.
The Sannabis Human Fine Pharmacy will operate within the temporary regulatory window granted to pharmacies authorized to dispense cannabis flower with a prescription, putting Sannabis in an early-mover position to serve medical patients across Colombia.
Colombia now has a complete regulatory framework, with certified seeds, planted by licensed cultivators, of flowers being dispensed by licensed authorized pharmacies.
For more information, visit www.sannabis.co, or follow Sannabis on social media for updates on the acquisition, product launches, and international initiatives.
About Sannabis, Inc. (OTC:USPS)
Sannabis, Inc. (OTC: USPS), formerly Ultimate Sports, Inc., is a U.S.-based company focused on the legal cannabis and hemp industry in Colombia. The company is finalizing the acquisition of Sannabis S.A.S. in Colombia, a fully licensed, vertically integrated cannabis producer and innovator with a strong commitment to social and environmental responsibility. Sannabis, Inc. has amended their articles of incorporation with the Indiana Secretary of State and changed their name from Ultimate Sports, Inc. A name change action has been initiated with FINRA which is still open. Until approved, they will trade as Ultimate Sports, Inc. (OTC: USPS), they plan to keep the USPS stock symbol.
Media Contact:
Investor Relations
Sannabis, Inc.
Email: [email protected]
Website: www.Sannabis.co
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other applicable securities laws. Forward-looking statements are based on current expectations, estimates, and projections about the business and industry of Sannabis, Inc. or Sannabis S.A.S., as well as management's beliefs and assumptions. Words such as "expects," "intends," "plans," "anticipates," "believes," "projects," "potential," "may," "will," "should," and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks, uncertainties, and assumptions that are difficult to predict. Actual results and outcomes may differ materially from those expressed or implied by such forward-looking statements, including but not limited to: the completion of the acquisition of Sannabis S.A.S.; the timing and impact of regulatory approvals in Colombia and other jurisdictions; the commercial success of Sannabis products and SannaCoin; the ability to secure financing; and general economic and market conditions. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Except as required by law, Sannabis, Inc. or Sannabis S.A.S. undertake no obligation to update or revise any forward-looking statements to reflect new information, future events, or otherwise.
SOURCE: Sannabis S.A.S.
View the original press release on ACCESS Newswire
K.Hill--AT